Nexus CMC Advisors

At Nexus CMC Advisors, we specialize in guiding clinical stage pharmaceutical and biotechnology companies through the complexities of CMC (Chemistry, Manufacturing, and Controls) regulatory affairs for the US market (i.e., FDA). Our expertise lies in clinical-stage and marketing submissions for small molecule, oligonucleotide, and peptide-based therapeutic products. With a deep understanding of regulatory requirements and a commitment to excellence, we help our clients navigate the regulatory landscape efficiently and effectively, ensuring their innovative therapies reach the market.